3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Tachycardia, Supraventricular
1
Heart Failure
1
Cardiotoxicity
1
Atrial Fibrillation
1
Arrhythmias, Cardiac
1
Interventions
Doxorubicin
11
Razoxane
5
Dexrazoxane
5
Electrocardiography
4
Echocardiography
4
Cyclophosphamide
4
Vincristine
3
Trastuzumab
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Exercise
3
Etoposide
3
Carvedilol
3
Radiotherapy
2
Prednisone
2
Methotrexate
2
Magnetic Resonance Spectroscopy
2
Bleomycin
2
salicylhydroxamic acid
1
oblimersen
1
hydrocortisone hemisuccinate
1
dapagliflozin
1
Vascular Stiffness
1
VAP-cyclo protocol
1
Tablets
1
Silymarin
1
Reverse Transcriptase Polymerase Chain Reaction
1
Resistance Training
1
Pulse Wave Analysis
1
Palliative Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cardiotoxicity
×
Gonadal Steroid Hormones
×
Clear all
NCT03243604
2018-10-18
ARBITRAGE
Groupe Hospitalier Pitie-Salpetriere
Completed
1,717 enrolled